Navigation Links
Cholesterol Lowering Statins may Prevent Parkinson’s Diseas

US researchers from University of North Carolina have reported an interesting find: statins, or drugs used to reduce levels of LDL or bad cholesterol may actually have an added benefit; //reduce the chance of developing Parkinson’s disease.

At present, around a million Australians use pop statins, which are lipid-modifying drugs that reduces body fat. It is currently the most prescribed drug for reducing cholesterol levels.

The drug is meant to prevent hardening or narrowing of arteries, which lead to coronary diseases, including heart diseases and stroke.

The study, which was based on 124 patients and 112 control subjects, is not viewed with much enthusiasm among Australian doctors who term the study as small and the results contradictory.

The researchers had found those with reduced LDL levels were up to three times more likely to be in the Parkinson's group.

'Interestingly, use of either cholesterol-lowering drugs, or statins alone is related to lower PD (Parkinson's disease) occurrence.’ the researchers claim.

Cardiologist Murray Esler, assistant director of Melbourne's Baker Heart Research Institute, said it was too small a study and Parkinson's patients probably develop low cholesterol as a result of having Parkinson's because the disease made it harder for them to feed and look after themselves.

Yet researchers are now planning a huge trial involving more than 16,000 patients to test this newly found association.
AN
'"/>




Page: 1

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Eating More Often May Help Lower Cholesterol
3. Caution On Use of Cholesterol Drugs
4. High Cholesterol linked to Alzheimer’s diseas
5. Cholesterol Drug Helps After Angioplasty
6. Cholesterol lowering drugs increase neuropathy risk
7. Almonds Improve Cholesterol
8. Cholesterol-lowering therapy benefits older people also
9. Cholesterol lowering drugs aid people after heart transplant
10. New Cholesterol gene linked to Alzheimers
11. Children’s Cholesterol Matter
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is ... in 1991 that this journey would have taken me into so many learning experiences ... Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the ...
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: